Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis

By  

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 465-477

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor

By Giorgi Mariano A   Cohen Arazi Hernáán   Gonzalez Claudio D   Di Girolamo Guillermo  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1285-1295

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor

By  

Current Pharmaceutical Design, Vol. 22, Iss. 13, 2016-04 ,pp. : 1918-1932

Bentham Science Publishers

Access to resources Recommend Favorite

The discovery and development of prasugrel

By Shan Jiaqi   Sun Hongbin  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 7, 2013-08 ,pp. : 897-905

Informa Healthcare

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y₁₂ receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J   Suryadevara Siva   Capranzano Piera   Bass Theodore A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite